These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

534 related items for PubMed ID: 16153572

  • 21. [Why use long-term macrolide therapy in pediatric pulmonology?].
    Corvol H, Taytard J, Thouvenin G, Périsson C, Nathan N, Clement A.
    Arch Pediatr; 2014 Mar; 21(3):314-21. PubMed ID: 24503457
    [Abstract] [Full Text] [Related]

  • 22. Immunomodulatory effects of macrolide antibiotics - part 2: advantages and disadvantages of long-term, low-dose macrolide therapy.
    Altenburg J, de Graaff CS, van der Werf TS, Boersma WG.
    Respiration; 2011 Mar; 81(1):75-87. PubMed ID: 20733282
    [Abstract] [Full Text] [Related]

  • 23. Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion.
    Aktan B, Taysi S, Gümüştekin K, Uçüncü H, Memişoğullari R, Save K, Bakan N.
    Pol J Pharmacol; 2003 Mar; 55(6):1105-10. PubMed ID: 14730107
    [Abstract] [Full Text] [Related]

  • 24. [Macrolides in antibiotic therapy of infections of the bronchial tree].
    Płusa T.
    Pol Merkur Lekarski; 2011 Sep; 31(183):139-44. PubMed ID: 21991841
    [Abstract] [Full Text] [Related]

  • 25. Long-term macrolide treatment for chronic respiratory disease.
    Spagnolo P, Fabbri LM, Bush A.
    Eur Respir J; 2013 Jul; 42(1):239-51. PubMed ID: 23180583
    [Abstract] [Full Text] [Related]

  • 26. [Clinical basis of macrolides apply in diseases of the respiratory tract].
    Płusa T.
    Pol Merkur Lekarski; 2008 Nov; 25(149):432-6. PubMed ID: 19177783
    [Abstract] [Full Text] [Related]

  • 27. [Effects of azithromycin on the virulence of Pseudomonas aeruginosa].
    Reinert P.
    Pathol Biol (Paris); 1995 Jun; 43(6):551-3. PubMed ID: 8539081
    [Abstract] [Full Text] [Related]

  • 28. [LONG TERM TREATMENT WITH MACROLIDES IN CHRONIC LUNG DISEASES].
    Shteinberg M, Schneer S, Lavon O, Adir Y.
    Harefuah; 2016 Sep; 155(9):567-571. PubMed ID: 28530085
    [Abstract] [Full Text] [Related]

  • 29. Clinical implications of macrolide resistance in community-acquired respiratory tract infections.
    Hoban DJ, Zhanel GG.
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):973-80. PubMed ID: 17181414
    [Abstract] [Full Text] [Related]

  • 30. Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease.
    Pukhalsky AL, Shmarina GV, Kapranov NI, Kokarovtseva SN, Pukhalskaya D, Kashirskaja NJ.
    Mediators Inflamm; 2004 Apr; 13(2):111-7. PubMed ID: 15203552
    [Abstract] [Full Text] [Related]

  • 31. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
    Tazumi A, Maeda Y, Goldsmith CE, Coulter WA, Mason C, Millar BC, McCalmont M, Rendall J, Elborn JS, Matsuda M, Moore JE.
    J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
    [Abstract] [Full Text] [Related]

  • 32. Anti-inflammatory therapy in cystic fibrosis.
    Dinwiddie R.
    J Cyst Fibros; 2005 Aug; 4 Suppl 2():45-8. PubMed ID: 16005266
    [Abstract] [Full Text] [Related]

  • 33. Immunomodulatory effects of macrolide antibiotics in respiratory disease: therapeutic implications for asthma and cystic fibrosis.
    Sharma S, Jaffe A, Dixon G.
    Paediatr Drugs; 2007 Aug; 9(2):107-18. PubMed ID: 17407366
    [Abstract] [Full Text] [Related]

  • 34. [Macrolides. Antiinflammatory and immunomodulator effects. Indication in respiratory diseases].
    Sacre Hazouri JA.
    Rev Alerg Mex; 2006 Aug; 53(3):108-22. PubMed ID: 16970113
    [Abstract] [Full Text] [Related]

  • 35. Use of macrolides and tetracyclines for chronic inflammatory diseases.
    Voils SA, Evans ME, Lane MT, Schosser RH, Rapp RP.
    Ann Pharmacother; 2005 Jan; 39(1):86-94. PubMed ID: 15562139
    [Abstract] [Full Text] [Related]

  • 36. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.
    Zarogoulidis P, Papanas N, Kioumis I, Chatzaki E, Maltezos E, Zarogoulidis K.
    Eur J Clin Pharmacol; 2012 May; 68(5):479-503. PubMed ID: 22105373
    [Abstract] [Full Text] [Related]

  • 37. Macrolide antibiotics in the treatment of asthma. An update.
    Hernando-Sastre V.
    Allergol Immunopathol (Madr); 2010 May; 38(2):92-8. PubMed ID: 20171003
    [Abstract] [Full Text] [Related]

  • 38. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?
    King P.
    Drugs; 2007 May; 67(7):965-74. PubMed ID: 17488142
    [Abstract] [Full Text] [Related]

  • 39. [Usefulness of macrolides as anti-inflammatories in respiratory diseases].
    Sevilla-Sánchez D, Soy-Muner D, Soler-Porcar N.
    Arch Bronconeumol; 2010 May; 46(5):244-54. PubMed ID: 19962815
    [Abstract] [Full Text] [Related]

  • 40. Antibiotic use among children in British Columbia, Canada.
    Marra F, Patrick DM, Chong M, Bowie WR.
    J Antimicrob Chemother; 2006 Oct; 58(4):830-9. PubMed ID: 16921182
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.